News - Appointments

The Dutch genomics company Cergentis BV has appointed Joris Schuurmans as chief executive and Dirk Pollet and Maja Sanders as members of its supervisory board.

Mereo BioPharma Group Plc, which focuses on oncology and rare diseases, has appointed John Lewicki as chief scientific officer, and Ann Kapoun as senior vice president of translational research and develo

Quell Therapeutics Ltd has made two new appointments to its board and announced a new senior vice president for research and translation.

uniQure NV of the Netherlands has announced the appointment of Leonard Post to its board of directors.

The Danish biotechnology company Zealand Pharma A/S has appointed Frank Sanders as president of its US operations.

Scenic Biotech BV of the Netherlands has announced the appointment of Oscar Izeboud as chief executive.

The Swedish pharmaceutical company Oncopeptides AB has announced the appointment of Marty Duvall as chief executive.

Marie Svensson is to join the Swedish biotechnology company Alligator Bioscience AB as chief financial officer on 1 September.

Kiadis Pharma NV has appointed Ray Barlow as chief business officer and Govert Schouten as head of innovation to help advance the company’s cell therapies for the treatment of liquid and solid tumours.

Claude Knopf, a former Novartis executive, has joined ImCheck Therapeutics SAS of Marseille, France as chief business officer. He will be located in Boston, US. ImCheck is developing antibody drug candidates targeting the butyrophilin superfamily of immune system regulators.